Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 382

The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.

Nanoparticle Characterization: State of the Art, Challenges, and Emerging Technologies

Open access
Cho, Eun Jung, Holback, Hillary, Liu, Karen C., Abouelmagd, Sara A., Park, Joonyoung, Yeo, Yoon·2013·Molecular Pharmaceutics

Abstract

Nanoparticles have received enormous attention as a promising tool to enhance target-specific drug delivery and diagnosis. Various in vitro and in vivo techniques are used to characterize a new system and predict its clinical efficacy. These techniques enable efficient comparison across nanoparticles and facilitate a product optimization process. On the other hand, we recognize their limitations as a prediction tool, due to inadequate applications and overly simplified test conditions. We provide a critical review of in vitro and in vivo techniques currently used for evaluation of nanoparticles and introduce emerging techniques and models that may be used complementarily.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/mp300697h

Cites

181 of 181 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 181 references

Research works printed but not linked: 33

  1. Saveyn H., 2010, J. Colloid Interface Sci., 352, 593, 10.1016/j.jcis.2010.09.006 · doi:10.1016/j.jcis.2010.09.006
  2. Finder C., 2004, Part. Part. Syst. Charact., 21, 372, 10.1002/ppsc.200400948 · doi:10.1002/ppsc.200400948
  3. Bowen P., 2002, J. Dispersion Sci. Technol., 23, 631, 10.1081/DIS-120015368 · doi:10.1081/dis-120015368
  4. Accardo A., 2004, J. Am. Chem. Soc., 126, 3097, 10.1021/ja039195b · doi:10.1021/ja039195b
  5. Needham D., 2000, Cancer Res., 60, 1197
  6. Pişkin E., 2004, Int. J. Pharm., 277, 105, 10.1016/j.ijpharm.2003.06.003 · doi:10.1016/j.ijpharm.2003.06.003
  7. Isaacs S. R., 2005, Chem. Mater., 18, 107, 10.1021/cm0518980 · doi:10.1021/cm0518980
  8. Matsumura Y., 1986, Cancer Res., 46, 6387
  9. Zhang W., 2008, J. Microencapsulation, 25, 203, 10.1080/02652040701852181 · doi:10.1080/02652040701852181
  10. Boackle R., 1983, Mol. Immunol., 20, 1157, 10.1016/0161-5890(83)90139-6 · doi:10.1016/0161-5890(83)90139-6
  11. Suzuki Y., 2003, Carbohydr. Polym., 54, 465, 10.1016/j.carbpol.2003.07.002 · doi:10.1016/j.carbpol.2003.07.002
  12. Ekkapongpisit M., 2012, Int. J. Nanomed., 7, 4147
  13. Anirudhan T. S., 2011, New J. Chem., 35, 2869, 10.1039/c1nj20672a · doi:10.1039/c1nj20672a
  14. Han S. E., 2009, J. Drug Targeting, 17, 123, 10.1080/10611860802472461 · doi:10.1080/10611860802472461
  15. Lei T. J., 2011, Nanomedicine, 7, 324, 10.1016/j.nano.2010.11.004 · doi:10.1016/j.nano.2010.11.004
  16. Mitra M., 2012, Mol. Vision, 18, 1361
  17. Huang S. K., 1992, Cancer Res., 52, 6774
  18. Vaage J., 1994, Cancer, 73, 1478, 10.1002/1097-0142(19940301)73:5<1478::AID-CNCR2820730526>3.0.CO;2-1 · doi:10.1002/1097-0142(19940301)73:5<1478::aid-cncr2820730526>3.0.co;2-1
  19. Vaage J., 1993, Cancer, 72, 3671, 10.1002/1097-0142(19931215)72:12<3671::AID-CNCR2820721219>3.0.CO;2-U · doi:10.1002/1097-0142(19931215)72:12<3671::aid-cncr2820721219>3.0.co;2-u
  20. Van Oosterom A. T., 1986, Eur. J. Cancer Clin. Oncol., 22, 601, 10.1016/0277-5379(86)90050-7 · doi:10.1016/0277-5379(86)90050-7
  21. Lawton P. A., 1993, Clin. Oncol. (R. Coll. Radiol.), 5, 80, 10.1016/S0936-6555(05)80851-9 · doi:10.1016/s0936-6555(05)80851-9
  22. Cowan J. D., 1985, Invest. New Drugs, 3, 149, 10.1007/BF00174162 · doi:10.1007/bf00174162
  23. Pfeiffer P., 1992, Acta Oncol., 31, 219, 10.3109/02841869209088906 · doi:10.3109/02841869209088906
  24. Li C., 1998, Cancer Res., 58, 2404
  25. McDonald D. M., 2002, Cancer Res., 62, 5381
  26. Kuo T. H., 1993, Anticancer Res., 13, 627
  27. Hoffman R. M., 2005, Methods Mol. Med., 111, 297
  28. Chishima T., 1997, Cancer Res., 57, 2042
  29. El Hilali N., 2002, Lab. Invest., 82, 1563, 10.1097/01.LAB.0000036877.36379.1F · doi:10.1097/01.lab.0000036877.36379.1f
  30. Oh P., 2009, FASEB J., 23, 438.11
  31. Frost G. I., 2005, Microvasc. Res., 69, 1, 10.1016/j.mvr.2004.10.001 · doi:10.1016/j.mvr.2004.10.001
  32. Dibirdik I., 2010, J. Nanomed. Nanotechnol., 1, 001, 10.4172/2157-7439.1000101 · doi:10.4172/2157-7439.1000101
  33. Uckun F. M., 2004, Arzneim. Forsch., 54, 715

Cited by

Metadata

Authors
Cho, E. J., Holback, H., Liu, K. C., Abouelmagd, S. A., Park, J., & Yeo, Y.
Venue
Molecular Pharmaceutics
Published
2013-03-21
Volume
10
Issue
6
Pages
2093-2110
ISSN
  • 1543-8384 (ISSN-L)
  • 1543-8392
OpenAlex
W1990424094
Cited by
382
References
181
FWCI
9.34
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.